No association between IFNL3 (IL28B) genotype and response to peginterferon alfa-2a in HBeAg-positive or -negative chronic hepatitis B

511 HBSAG LEVELS DECLINE DURING PEGINTERFERON ALFA-2A [40KD] (PEGASYS) TREATMENT IN PATIENTS WITH HBEAG-NEGATIVE CHRONIC HEPATITIS B FAVORS 6 MONTHS POST-TREATMENT RESPONSE: PERSEAS COHORT INTERIM ANALYSIS

10.1016/s0168-8278(12)60524-8 ◽

2012 ◽

Vol 56 ◽

pp. S201-S202

Author(s):

I. Goulis ◽

E. Akriviadis ◽

S. Karatapanis ◽

M. Deutsch ◽

G. Dalekos ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Treatment Response ◽

Chronic Hepatitis B ◽

Interim Analysis ◽

Post Treatment ◽

Peginterferon Alfa ◽

Hepatitis B virus surface antigen levels: A guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B

Hepatology ◽

10.1002/hep.22760 ◽

2008 ◽

Vol 49 (4) ◽

pp. 1141-1150 ◽

Cited By ~ 327

Author(s):

Maurizia Rossana Brunetto ◽

Francesco Moriconi ◽

Ferruccio Bonino ◽

George K. K. Lau ◽

Patrizia Farci ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B Virus ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Surface Antigen ◽

Sustained Response ◽

Virus Surface ◽

B Virus ◽

Peginterferon Alfa ◽

Virological and immunological predictors of long term outcomes of peginterferon alfa-2a therapy for HBeAg-negative chronic hepatitis B

Journal of the Formosan Medical Association ◽

10.1016/j.jfma.2020.12.001 ◽

2020 ◽

Author(s):

I-Cheng Lee ◽

Chien-Wei Su ◽

Keng-Hsin Lan ◽

Yuan-Jen Wang ◽

Kuei-Chuan Lee ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Long Term Outcomes ◽

Peginterferon Alfa ◽

1027 INTRAHEPATIC HBSAG PREDICTS TREATMENT RESPONSE IN HBEAG NEGATIVE CHRONIC HEPATITIS B (CHB) PATIENTS TREATED WITH PEGINTERFERON ALFA-2A AND ADEFOVIR; AN INTERIM ANALYSIS

10.1016/s0168-8278(10)61028-8 ◽

2010 ◽

Vol 52 ◽

pp. S397

Author(s):

B. Takkenberg ◽

A. De Niet ◽

V. Terpstra ◽

H. Zaaijer ◽

C. Weegink ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Treatment Response ◽

Chronic Hepatitis B ◽

Interim Analysis ◽

Peginterferon Alfa ◽

Faculty Opinions recommendation of On-treatment prediction of sustained response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B patients.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725223832.793501442 ◽

2014 ◽

Author(s):

Philip Rosenthal

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Sustained Response ◽

Treatment Prediction ◽

Peginterferon Alfa ◽

Extended peginterferon alfa-2a (Pegasys) therapy in Chinese patients with HBeAg-negative chronic hepatitis B

Journal of Medical Virology ◽

10.1002/jmv.24013 ◽

2014 ◽

Vol 86 (10) ◽

pp. 1705-1713 ◽

Cited By ~ 15

Author(s):

Xuefu Chen ◽

Xiaoping Chen ◽

Wenli Chen ◽

Xiaojun Ma ◽

Jing Huang ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Chinese Patients ◽

Peginterferon Alfa ◽

95 Peginterferon alfa-2A (40KD) (PEGASYS®) monotherapy is more effective than lamivudine monotherapy in the treatment of HBEAG-negative chronic hepatitis B: 72-week results from a phase III, partially double-blind study of PEGASYS® alone vs PEGASYS® plus lamivudine vs lamivudine

10.1016/s0168-8278(04)90095-5 ◽

2004 ◽

Vol 40 ◽

pp. 34 ◽

Cited By ~ 3

Author(s):

P. Marcellin ◽

G.K.K. Lau ◽

F. Bonino ◽

P. Farci ◽

S. Hadziyannis ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Blind Study ◽

Phase Iii ◽

Double Blind Study ◽

Double Blind ◽

Lamivudine Monotherapy ◽

Peginterferon Alfa ◽

714 HBSAG LEVELS DURING THE FIRST 24 WEEKS OF PEGINTERFERON ALFA-2A [40KD] (PEGASYS) TREATMENT IN PATIENTS WITH HBEAG-NEGATIVE CHRONIC HEPATITIS B: THE PERSEAS COHORT

10.1016/s0168-8278(11)60716-2 ◽

2011 ◽

Vol 54 ◽

pp. S286-S287

Author(s):

I. Goulis ◽

E. Akriviadis ◽

S. Karatapanis ◽

M. Deutsch ◽

G. Dalekos ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Peginterferon Alfa ◽

Peginterferon Alfa-2a Alone, Lamivudine Alone, and the Two in Combination in Patients with HBeAg-Negative Chronic Hepatitis B

New England Journal of Medicine ◽

10.1056/nejmoa040431 ◽

2004 ◽

Vol 351 (12) ◽

pp. 1206-1217 ◽

Cited By ~ 783

Author(s):

Patrick Marcellin ◽

George K.K. Lau ◽

Ferruccio Bonino ◽

Patrizia Farci ◽

Stephanos Hadziyannis ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Chronic Hepatitis B ◽

Peginterferon Alfa ◽

A genotype-specific baseline score predicts post-treatment response to peginterferon alfa-2a in Hepatitis B e antigen-negative chronic hepatitis B

Annals of Gastroenterology ◽

10.20524/aog.2018.0300 ◽

2018 ◽

Author(s):

Pietro Lampertico

Keyword(s):

Chronic Hepatitis ◽

Hepatitis B ◽

Treatment Response ◽

Chronic Hepatitis B ◽

Post Treatment ◽

Baseline Score ◽

Hepatitis B E Antigen ◽

Peginterferon Alfa ◽